Denali Biomedical data breach
Incident readout
- Company
- Denali Biomedical
- Reported to
- Illinois Attorney General
- Filed
- June 13, 2025
- People affected
- Not stated in the filing
- Incident type in filing
- Not stated
- Our review
- Investigation Open
Was this a ransomware attack?
The filing does not say ransomware was involved. We do not label an incident ransomware unless the company’s report says so. Whatever the cause, the steps to protect yourself and the legal question are the same.
What we know
Denali Biomedical operates at the sophisticated intersection of medical device manufacturing, orthopedic and neurological research, and clinical data analytics. As a specialized biomedical enterprise, the organization partners closely with hospitals, surgical centers, and clinical research institutions to supply advanced medical technologies and monitor post-operative patient outcomes. Because of this specialized role, Denali Biomedical acts as a vital repository for an immense volume of highly confidential data, ranging from proprietary medical device telemetry and clinical trial participant registries to detailed patient health histories, billing records, and practitioner credentials. The sheer concentration of valuable intellectual property and deeply personal medical information makes the company an unavoidable target for sophisticated cybercriminal syndicates seeking to exploit high-value health sector networks. In 2025, Denali Biomedical formally reported a significant security incident to the Illinois Attorney General, alerting regulators and consumers to an unauthorized intrusion into its digital environment. While exact forensic findings continue to emerge, incidents impacting biomedical firms typically involve advanced persistent threats, unauthorized access to centralized research and patient databases, or vulnerabilities introduced through third-party vendor ecosystems. In the medical technology sector, these breaches often manifest as ransomware deployments or targeted data exfiltration campaigns designed to extract proprietary product designs alongside vulnerable patient and employee dossiers. Such an incident points to potential gaps in perimeter defense, inadequate network segmentation, or delayed patching protocols that allowed malicious actors to dwell within the system undetected. The exposure resulting from the Denali Biomedical breach encompasses a dangerous mosaic of sensitive information, exposing victims to profound and long-lasting risks. Compromised records frequently include full legal names, dates of birth, Social Security numbers, health insurance details, and specific medical device or treatment data. When medical and biographical details are combined, bad actors gain the exact ingredients necessary to execute medical identity theft—such as fraudulently billing insurance providers, intercepting necessary medical treatments, or draining financial accounts. Furthermore, the exposure of personnel records, vendor files, and research credentials leaves individuals vulnerable to targeted phishing schemes, synthetic identity creation, and unauthorized tax filings. Under federal and state law, including the Health Insurance Portability and Accountability Act (HIPAA) and the Illinois Personal Information Protection Act, Denali Biomedical had strict, legally binding obligations to implement robust administrative, physical, and technical safeguards to protect sensitive health and personal information. These mandates require continuous network monitoring, encryption of data at rest and in transit, and stringent vendor risk management. The occurrence of a data breach of this magnitude serves as prima facie evidence of potential systemic failures to meet these regulatory standards, suggesting that the company may have fallen short of its duty of care owed to patients, research participants, and employees. Receiving a data breach notification letter from Denali Biomedical is a formal admission by the company that your confidential information was compromised due to its inadequate security infrastructure. Legally, this notification establishes the necessary standing to participate in a class action lawsuit aimed at holding the corporation accountable for its negligence. You do not need to prove that you have already suffered actual financial loss or medical fraud to take legal action; simply having your private data exposed is actionable. Our firm handles these complex class action cases on a strict contingency fee basis, meaning you pay nothing out of pocket, and we only collect a fee if we successfully recover compensation on your behalf.
See every breach reported in Illinois or read what to do after a ransomware attack.
After the Denali Biomedical incident: what to do and your options
- What should I do after getting the Denali Biomedical data breach notice?
- Keep the letter and the envelope, and note the date it arrived. Freeze your credit with Equifax, Experian and TransUnion, change any passwords the notice mentions, and sign up for any free credit monitoring the letter offers. Then check whether you may have a claim.
- Did Denali Biomedical offer free credit monitoring?
- Any free monitoring Denali Biomedical is offering will be described in the notice you received, along with an activation code and a sign-up deadline. Using the free service won't stop you from joining a lawsuit or settlement later.
- Can I sue Denali Biomedical over the data breach?
- It depends on what was exposed, the law in Illinois and your own state, and whether you've been harmed. Most people take part through a class action rather than suing alone. Keep your notification letter — it's the proof that connects you to the breach.
- Do I need a Denali Biomedical data breach lawyer or attorney?
- Whether the company's systems were encrypted by ransomware or data was simply taken, the legal question is the same: did it protect your information the way the law requires? An attorney can review your notice for free, and these cases are usually handled on contingency.
- Is there a Denali Biomedical data breach class action lawsuit?
- Law firms often open an investigation after a breach notice like this one, and a class action lawsuit may follow. This page doesn't confirm that a lawsuit has been filed against Denali Biomedical. You usually don't have to join a class action to be included — if a settlement is reached, class members are notified and can file a claim.
- Is the Denali Biomedical data breach letter legit or a scam?
- A notice from Denali Biomedical in the mail matches the breach Denali Biomedical reported to the Illinois Attorney General on June 13, 2025. Check that the company name and dates in your letter match that filing. A real notice of data security incident won't ask for your password, Social Security number or a payment — if it does, contact Denali Biomedical through a phone number or website you find yourself.
- How much could a Denali Biomedical data breach settlement or claim be worth?
- There is no set amount, and no Denali Biomedical settlement is confirmed here. In past data breach settlements, payments depended on what data was exposed and on documented losses — fraud, out-of-pocket costs and time spent dealing with the breach. Keep receipts and records; they're what damages claims are built on.
Other breaches reported in Illinois
- The University Of Illinois College Of Medicine - ChicagoIllinois Attorney General · Filed July 14, 2026Count not stated
- Abbott Cancer Diagnostics (Formerly Known As Exact Sciences)Illinois Attorney General · Filed July 8, 2026Count not stated
- Aspire Rural Health SystemIllinois Attorney General · Filed July 7, 2026Count not stated
- EVERSANA LIFE SCIENCES SERVICESIL Attorney General · Filed June 30, 2026Count not stated
- EVERSANA LIFE SCIENCES SERVICESIllinois Attorney General · Filed June 30, 2026Count not stated
- EduPath Learning PlatformIllinois Attorney General · Filed June 25, 202678,000 affected
Attorney advertising. This page reflects a public regulator filing; it does not mean a lawsuit has been filed or that the company did anything unlawful. Submitting a review request does not create an attorney-client relationship.